The largest database of trusted experimental protocols

Cd69 apc

Manufactured by BD
Sourced in United States

CD69-APC is a fluorescent-labeled antibody used in flow cytometry for the detection and analysis of CD69 expression on immune cells. CD69 is an early activation marker expressed on the surface of activated lymphocytes, including T cells, B cells, and natural killer cells. The APC (Allophycocyanin) fluorescent label allows for the visualization and quantification of CD69-positive cells.

Automatically generated - may contain errors

19 protocols using cd69 apc

1

Quantification of Extracellular Vesicle Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface receptor expression was measured with CD69 (APC), or CD45 (PE) antibodies (BD Biosciences) using the manufacturer’s recommendations. Cells were incubated on ice for 1 hour, washed 3 times with PBS and fixed in 2% paraformaldehyde (Polysciences). Purified extracellular cellular vesicles (EV) were stained with either anti-CD63 exo-flow staining kit (Systems Biosciences) or CFSE dye (5μM) for 15 minutes at 37°C. EVs were washed in PBS four times and concentrated using Amicon 100K filter units (Millipore). Data was acquired on BD LSR II flow cytometer using single stained CompBeads (BD Biosciences) for compensation. At least 10,000 total events were collected in each experiment and the FlowJo software program (Tree Star Inc.) was used for data analysis. All flow cytometry experiments were repeated at least three times with consistent results.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cultures were collected, washed, incubated for 15 min with mouse mAbs against human CD3-PerCP, CD56-FITC, or PE, CD69-APC, CD16-PE (BD Biosciences, USA), and NKG2D-PE (BioLegend, USA). NK cells were incubated with CD158a-PE and CD158b-PE (BD Pharmingen, USA), CIK cells were incubated with CD4-PE and CD8-APC (BD Biosciences) and γδ T cells were incubated with Vγ9-FITC (BD Pharmingen), CD4-PE, and CD8-APC. Isotype-matched antibodies were used as controls. Perforin and granzyme B detection was performed according to the BD Cytofix/Cytoperm™ Kit manual (BD Biosciences). Briefly, NK, CIK, and γδ T cells were harvested and adjusted to 1 × 106 cells/mL in RPMI-1640 medium containing 10 % fetal calf serum, and incubated 0.1 % GolgiStop (BD Biosciences) for 4 h. After pre-incubation with 10 % normal human serum, cells were stained with mAbs to identify NK (CD3CD56+), CIK (CD3+CD56+), and γδ T cells (CD3+Vγ9+), followed by intracellular staining for perforin-PE and granzyme B-PE (BD Pharmingen), and the corresponding isotype antibodies to determine intracellular cytokine levels.
Flow cytometry data acquisition was performed on a BD FACS Calibur (BD Biosciences) with Cell Quest Pro software. Analysis was performed with FlowJo software (Tree Star, USA).
+ Open protocol
+ Expand
3

T-cell Stimulation and Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
On day 0, 7, and 14, the PBMCs from the T‐cell stimulation assay were analyzed in flow‐cytometry by anti‐CD3‐FITC, CD8‐PerCP, CD45RO‐PE, CD45RA‐APC‐H7, and CD69‐APC antibodies (BD, Heidelberg, Germany) with a FACS Canto II.
Cytotoxicity of effector cells that were stimulated for 14 days was tested by measuring LDH release with the CytoTox 96 Non‐Radioactive Cytotoxicity Assay (Promega, Madison, Wisconsin) following incubation with peptide loaded T2/mHLA‐A*24:02 cells at a ratio of 5:1. The cells were incubated for 4 hours at 37°C and LDH release was measured according to kit instructions.
+ Open protocol
+ Expand
4

Evaluation of B Cell Activation Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human whole blood collected at Stanford Blood Bank in sodium heparin was incubated for 1 hr at 37 °C/5% CO2 in a humidified incubator with a dilution series of compound or 0.5% DMSO alone as a control. Samples were then stimulated with 50 μg/ml of Goat F(ab')2 anti-human IgM (Southern Biotech Cat#2022-14) for 16-18 hrs in a 37 °C/5% CO2 humidified incubator. The blood was stained for CD69 antigen expression on human B cells with BD Biosciences antibodies CD20-FITC (Cat#555622), CD69-APC (Cat#5555633), and corresponding isotype controls according to manufacturer's recommendations. Red blood cells were lysed with 1X BD Biosciences Lysis buffer (Cat#555899) according to manufacturer's recommendations. Cells were washed and resuspended in 1% bovine serum albumin in PBS and analyzed via flow cytometry on a Cytex DxP11 instrument using FlowJo v7.6.4. The percent of CD69 positive cells was plotted as a function of inhibitor concentration and fit to a sigmoidal dose-response using GraphPad Prism software to evaluate inhibitor potency.
+ Open protocol
+ Expand
5

Immunophenotyping of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were stained without further separation to minimize selective losses shortly after collection. Combinations of the directly conjugated monoclonal antibodies CD3-V500, CD4-PerCP, CD56-PE, CD127-BV421, CD25-PE-CY7, CD25-APC, CD62L-FITC, CD69-APC, CD45RA-FITC, CCR7-PE, Ki67-FITC, Foxp3-APC (BD Bioscience, Mountain View, CA, USA), CD16-APC/CY7, HLADR-APC/CY7 (Biolegend, San Diego, CA, USA) and their relative allotypes were used in individual 8-color flow cytometry assays to analyze the immunophenotype of regulatory T cells and effector T cells.
Intracellular staining was performed using the Intracellular Staining Kit (eBioscience, San Diego, CA, USA). The expression of Ki67 was determined in freshly isolated CD4+CD25highFoxp3+ regulatory T cells. The cellular secretion and function of cytokines were determined after incubation of cells for 5 h with phorbol myristate acetate (PMA) (100 ng/ml) plus ionomycin (2 ug/ml, all reagents from Sigma Chemical Co., St. Louis, MO, USA) to stimulate maximal production of IL-17 and IFN-γ; GolgiStop (0.7 μl/ml) was added to the samples during the last 4 hours to sequester the proteins in the cytoplasm [22 (link),23 (link)].
+ Open protocol
+ Expand
6

Multicolor Flow Cytometry for T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
PFMC or PBMC were stained with LIVE/DEAD yellow fixable dead cell stain kit (Life Technology, Eugene, OR) and with the following two monoclonal antibody staining panels: In Panel 1, cells were surface-stained by anti-CD3-PerCP, CD4-PE-Cy7, CD45RO-FITC, CD69-APC, CD38-AF700 (BD Bioscience, San Jose, CA), CD8-PE-TR (Invitrogen, Frederick, MD), CCR7-APC-Cy7 and HLADR-Pacific Blue (BioLegend, San Diego, CA). Cells were then fixed, permeabilized, and washed with Transcription Factor Buffer Set (BD Pharmingen) according to the manufacturer and stained with anti-HIV-1 p24-PE (KC57) (Beckman Coulter, Indianapolis IN). In Panel 2, monoclonal antibodies included: anti CD25-APC (BioLegend), CCR5-V450 and intracellular staining for Ki67-BV711 (both from BD Bioscience) in addition to anti-CD3, CD4, CD8, CCR7, CD45RO, and HIV-1 p24 as in panel 1. Gates were set using Fluorescent-Minus-One controls for each sample. T cells were identified as naïve (CD45RO-CCR7+), central memory (Tcm) (CD45RO+CCR7+), effector memory (Tem) (CD45RO+CCR7-), and terminally differentiated effector memory (TemRA) (CD45RO-CCR7-). Stained samples were analyzed by a LSRII cytometer (BD). Data were analyzed using FlowJo (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
7

Profiling Circulating Immune Cells Post-Cardiac Bleed

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood obtained from cardiac bleeds was used to profile circulating immune cells after red blood cell lysis (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.3). Cells were stained with the following antibodies: CD8a-PE-Cy7 (53-6.7), CD4-APC-Cy7 (GK1.5), CD69-APC (H1.2F3), CD279-PE (J43), Ly6G-BV421 (1A8), B220 Pe-Cy5, CD103 bv510, CD11b BV605, CD11c Percpm, CD206 APC, CD25 APC, CD27 A-Cy7, CD4 A-Cy7, CD4 Pe-Cy7, CD44 FITC, CD62L BV450, CD69 FITC, CD69 Pe-Cy7, CD8 A-Cy7, CD8 APC, CD8 Pe-Cy5, CD8 Pe-Cy7, CD80 PE, F4/80 Pe-Cy7, FOXP3 FITC, H2-Kd FITC, IFNAR1 PE, IFNg PE, Ly6C-APC, Ly6G BV711, MHC-II BV650, NKG2D Pe-Cy7, NKp46 BV421, PD1 PE, PDL1 BV421, Rat IgG2a FITC, TCRbeta BV510, TNFa FITC (all from BD Biosciences) and Ly6C-APC (HK1.4) (Biolegend). Primary tumors were mechanically and enzymatically digested with 1 mg/mL collagenase I (Sigma) and 30 μg/mL DNAse I (Sigma) at 37 °C to obtain a single cell suspension before red blood cell lysis. Analysis of tumor-infiltrating lymphocytes was done as above. Analysis of immune cell populations was performed by flow cytometry using a FACSCanto II (BD Biosciences, USA). Data was analyzed using Flowjo software (TreeStar, USA).
+ Open protocol
+ Expand
8

Evaluation of B Cell Activation Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human whole blood collected at Stanford Blood Bank in sodium heparin was incubated for 1 hr at 37 °C/5% CO2 in a humidified incubator with a dilution series of compound or 0.5% DMSO alone as a control. Samples were then stimulated with 50 μg/ml of Goat F(ab')2 anti-human IgM (Southern Biotech Cat#2022-14) for 16-18 hrs in a 37 °C/5% CO2 humidified incubator. The blood was stained for CD69 antigen expression on human B cells with BD Biosciences antibodies CD20-FITC (Cat#555622), CD69-APC (Cat#5555633), and corresponding isotype controls according to manufacturer's recommendations. Red blood cells were lysed with 1X BD Biosciences Lysis buffer (Cat#555899) according to manufacturer's recommendations. Cells were washed and resuspended in 1% bovine serum albumin in PBS and analyzed via flow cytometry on a Cytex DxP11 instrument using FlowJo v7.6.4. The percent of CD69 positive cells was plotted as a function of inhibitor concentration and fit to a sigmoidal dose-response using GraphPad Prism software to evaluate inhibitor potency.
+ Open protocol
+ Expand
9

Flow Cytometry Analysis of Mouse and Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-human CD3e-V500, CD4-APC-H7, CD8-APC-H7, CD25-PE, CD39-PE (clone TU66), CD73-APC (clone AD2), PD1-PE-Cy7 (clone EH12.1), and CD127-PerCP-Cy5.5 antibodies were purchased by BD Biosciences (Germany), anti-human FOXP3-FITC antibody was from eBioscience (Germany). Anti-mouse CD3e-PerCP-Cy5.5, -APC, -V500 and -V450; CD4-APC, -BV421, -APC-Cy7 and -APC-H7; CD8a-APC-Cy7, -PE-Cy7 and -APC-H7; CD25-APC, -APC-Cy7 and -V450; CD44-PE; CD45-V500; CD45RB-PE; CD62 L-APC; CD69-APC; CD73-BV605 (clone TY/11.8) and PD1-PerCP-Cy5,5 (clone J43) were purchased by BD Biosciences (Germany). Purified anti-mouse CD3e and CD28, as well as FOXP3-FITC, CD73- eFluor® 450, -PE (clone TY/11.8 for both) and CD39-PE-Cy7, -PE (clone DM24S1 for both) were from eBioscience (Germany). BSA, Trypan blue, PMA, and Ionomycin were obtained from Sigma (Germany). Phosphate buffer saline (PBS), RPMI-1640 with L-glutamine and Penicillin-Streptomycin were purchased by PAA (Germany). Fetal bovine serum (FBS) was from PAN Biotech (Germany). Brefeldin A was purchased by BD Biosciences (Germany). Foxp3/Transcription Factor Staining Buffer Set and Permeabilization Buffer (10X) were obtained from eBioscience (Germany). Red Blood Cell (RBC) Lysis Buffer was from Biolegend (Germany).
+ Open protocol
+ Expand
10

Multiparameter Flow Cytometry Analysis of MR1-Restricted T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 1 x 106 T cells were washed with cold FACS staining buffer (1x PBS with 2% FBS) and stained with either: PE-conjugated control unloaded (empty) mouse MR1(K43A) tetramer or PE-conjugated rRL-6HM-loaded mouse MR1(K43A) tetramer at 20 μg/ml (1G tetramers; (4 (link))); or PE-conjugated non-stimulatory control mouse MR1(wild type)–6-FP tetramer or PE-conjugated mouse MR1(wild type)–5-OP-RU tetramer at 1.4 μg/ml (2G tetramers; (6 (link))) for 45 minutes at room temperature in the dark. Immediately thereafter, cells were co-stained for 30 minutes on ice with mixture of selected fluorochrome-conjugated antibodies including anti-mouse CD3-Pacific blue (BD Biosciences), CD4-PerCP or Alexa Fluor 700 (BioLegend), CD8α-APC-H7 (BD Biosciences), CD8β-Alexa Fluor 647 or PerCP-Cy5.5 (BioLegend), NK1.1-PerCP-Cy5.5 or -BV510 (clone PK136, BD Biosciences), CD69-APC, CD44-PE-Cy7, Vβ6/Vβ8.1–8.2 TCR-FITC (BD Biosciences), CXCR3-PE-Cy7 and α4β1 integrin-Alexa Fluor 647 (BioLegend). After washing once with 2 ml of FACS staining buffer, data was acquired on BD FACS CantoII, BD LSR II or BD FACSAria flow cytometers and analyzed using FlowJo analysis software (Tree Star).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!